Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jayashree Kalpathy-Cramer

Concepts (405)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinopathy of Prematurity
37
2026
179
6.520
 Why?
Artificial Intelligence
39
2025
365
5.300
 Why?
Image Processing, Computer-Assisted
24
2026
780
4.430
 Why?
Glioblastoma
16
2024
353
3.170
 Why?
Brain Neoplasms
24
2024
1318
3.090
 Why?
Machine Learning
23
2026
585
2.800
 Why?
Algorithms
41
2026
1837
2.740
 Why?
Uterine Cervical Neoplasms
8
2025
267
2.360
 Why?
Diagnostic Imaging
19
2024
338
2.140
 Why?
Radiology
10
2024
174
1.870
 Why?
Natural Language Processing
7
2023
103
1.830
 Why?
Magnetic Resonance Imaging
41
2024
3863
1.760
 Why?
Geographic Atrophy
2
2026
97
1.700
 Why?
Information Storage and Retrieval
8
2015
121
1.660
 Why?
Retina
7
2026
324
1.520
 Why?
Neuroimaging
7
2022
289
1.480
 Why?
Glioma
8
2022
425
1.380
 Why?
Image Interpretation, Computer-Assisted
14
2026
285
1.380
 Why?
Cervix Uteri
3
2025
50
1.340
 Why?
Radiotherapy Planning, Computer-Assisted
5
2016
149
1.240
 Why?
ROC Curve
17
2026
614
1.090
 Why?
Papillomavirus Infections
5
2025
345
1.080
 Why?
Software
10
2024
690
1.030
 Why?
Humans
165
2026
144759
1.020
 Why?
Colposcopy
2
2025
18
0.990
 Why?
Optic Disk
2
2025
53
0.960
 Why?
Telemedicine
8
2026
945
0.940
 Why?
Optical Imaging
1
2026
64
0.900
 Why?
Severity of Illness Index
10
2026
2925
0.880
 Why?
Glaucoma
2
2025
250
0.880
 Why?
Gestational Age
19
2026
975
0.880
 Why?
Tomography, X-Ray Computed
15
2023
2730
0.860
 Why?
Fundus Oculi
6
2026
89
0.850
 Why?
Infant, Newborn
37
2026
6429
0.850
 Why?
Retinal Vessels
7
2026
77
0.830
 Why?
Tomography, Optical Coherence
2
2025
271
0.810
 Why?
Reproducibility of Results
28
2025
3409
0.800
 Why?
Solitary Pulmonary Nodule
3
2021
23
0.770
 Why?
Radiology Information Systems
4
2022
35
0.760
 Why?
Privacy
1
2023
41
0.760
 Why?
Ophthalmology
5
2023
116
0.750
 Why?
Diagnostic Techniques, Ophthalmological
3
2018
53
0.740
 Why?
Breast Neoplasms
7
2024
2452
0.730
 Why?
Ophthalmoscopy
8
2024
38
0.690
 Why?
Radiologists
4
2024
60
0.680
 Why?
Bronchopulmonary Dysplasia
1
2026
410
0.650
 Why?
Neonatal Screening
6
2026
178
0.640
 Why?
Sensitivity and Specificity
14
2024
1985
0.640
 Why?
Crowdsourcing
1
2020
18
0.640
 Why?
Medicine
1
2021
125
0.610
 Why?
Breast Density
3
2024
8
0.590
 Why?
Mammography
4
2024
166
0.570
 Why?
Stroke
3
2023
1256
0.550
 Why?
Retrospective Studies
27
2026
17066
0.540
 Why?
Retinal Vein
4
2021
14
0.540
 Why?
Isocitrate Dehydrogenase
1
2017
70
0.520
 Why?
Infant, Premature
12
2026
611
0.520
 Why?
Female
60
2026
78271
0.510
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2016
109
0.480
 Why?
Lung Neoplasms
5
2021
2637
0.480
 Why?
Tumor Burden
4
2023
319
0.470
 Why?
Phenylurea Compounds
1
2016
112
0.470
 Why?
Databases, Factual
8
2021
1486
0.460
 Why?
Chemoradiotherapy
7
2023
237
0.450
 Why?
Gallbladder Neoplasms
3
2011
20
0.450
 Why?
Quinolines
1
2016
193
0.450
 Why?
Prostatic Neoplasms
5
2024
974
0.450
 Why?
Peripheral Arterial Disease
4
2023
503
0.450
 Why?
Radiography, Thoracic
5
2022
171
0.440
 Why?
Pattern Recognition, Automated
5
2023
74
0.440
 Why?
Benchmarking
6
2024
188
0.430
 Why?
Uterine Cervical Dysplasia
2
2025
27
0.430
 Why?
Delivery of Health Care
1
2021
947
0.420
 Why?
Hypertension, Pulmonary
1
2026
1980
0.420
 Why?
Male
54
2026
72315
0.420
 Why?
Subtraction Technique
1
2014
26
0.420
 Why?
Radiation Oncology
2
2014
88
0.410
 Why?
Retinal Artery
3
2021
17
0.410
 Why?
Photography
6
2021
115
0.410
 Why?
Vocabulary, Controlled
1
2014
47
0.410
 Why?
Early Detection of Cancer
5
2025
463
0.400
 Why?
Neoplasm Recurrence, Local
2
2019
1137
0.400
 Why?
White Matter
3
2023
153
0.400
 Why?
Phantoms, Imaging
7
2023
158
0.390
 Why?
Multimodal Imaging
1
2014
124
0.390
 Why?
Datasets as Topic
5
2021
122
0.370
 Why?
Middle Aged
32
2025
35875
0.360
 Why?
Aged
30
2025
25913
0.350
 Why?
Survival Analysis
4
2016
1382
0.350
 Why?
Cerebral Blood Volume
3
2020
5
0.350
 Why?
Radiotherapy, Conformal
1
2011
74
0.340
 Why?
Contrast Media
9
2020
488
0.340
 Why?
Internet
2
2014
699
0.330
 Why?
Mass Screening
4
2025
1347
0.330
 Why?
Adrenoleukodystrophy
2
2023
8
0.330
 Why?
Clinical Competence
2
2016
1244
0.320
 Why?
Proportional Hazards Models
4
2011
1325
0.320
 Why?
Brain
8
2021
2933
0.310
 Why?
Radiographic Image Interpretation, Computer-Assisted
2
2023
121
0.310
 Why?
Precision Medicine
3
2024
457
0.310
 Why?
Medical Informatics
4
2020
97
0.310
 Why?
Head and Neck Neoplasms
5
2020
558
0.300
 Why?
Neoplasms
7
2024
2875
0.290
 Why?
Database Management Systems
1
2008
50
0.280
 Why?
User-Computer Interface
4
2015
164
0.270
 Why?
Radiotherapy, Adjuvant
1
2008
222
0.270
 Why?
Automation
5
2020
102
0.260
 Why?
Endovascular Procedures
2
2023
384
0.260
 Why?
Observer Variation
4
2024
355
0.260
 Why?
Adult
27
2025
40449
0.250
 Why?
Lung
6
2022
4109
0.250
 Why?
Prognosis
9
2024
4282
0.250
 Why?
Risk Factors
10
2026
10779
0.250
 Why?
Radiography
5
2022
844
0.240
 Why?
Diffusion Magnetic Resonance Imaging
2
2018
154
0.230
 Why?
Endoscopy, Gastrointestinal
1
2007
237
0.230
 Why?
Antineoplastic Agents
1
2016
2194
0.220
 Why?
Rectal Neoplasms
2
2021
156
0.220
 Why?
Oropharyngeal Neoplasms
2
2015
55
0.220
 Why?
Uncertainty
1
2026
144
0.220
 Why?
Predictive Value of Tests
5
2025
2115
0.220
 Why?
Reference Standards
7
2021
177
0.210
 Why?
Neoplasm Grading
3
2024
307
0.210
 Why?
Adenocarcinoma in Situ
1
2023
1
0.210
 Why?
Forecasting
3
2019
391
0.200
 Why?
Statistics as Topic
2
2014
284
0.200
 Why?
Ranibizumab
1
2023
21
0.190
 Why?
Postoperative Care
2
2019
288
0.190
 Why?
Imaging, Three-Dimensional
4
2023
583
0.190
 Why?
Radiotherapy, Intensity-Modulated
4
2016
141
0.190
 Why?
Neovascularization, Pathologic
3
2024
286
0.190
 Why?
Diagnosis, Computer-Assisted
2
2021
91
0.190
 Why?
Biomedical Research
3
2024
710
0.190
 Why?
Myeloid-Derived Suppressor Cells
1
2023
72
0.180
 Why?
Long QT Syndrome
1
2023
69
0.180
 Why?
Documentation
2
2015
198
0.180
 Why?
Oxygen
2
2021
995
0.180
 Why?
Macular Degeneration
1
2024
191
0.180
 Why?
Quality Assurance, Health Care
2
2014
340
0.180
 Why?
Computer Communication Networks
2
2020
32
0.180
 Why?
Diverticulitis
1
2021
8
0.170
 Why?
Rheumatic Diseases
1
2022
97
0.170
 Why?
Patient-Specific Modeling
2
2024
45
0.170
 Why?
Infant
11
2024
10034
0.170
 Why?
Biomarkers
4
2018
4271
0.170
 Why?
Cohort Studies
6
2022
5960
0.170
 Why?
Hospital Units
1
2021
32
0.170
 Why?
Musculoskeletal System
1
2021
49
0.160
 Why?
Intestinal Obstruction
1
2021
56
0.160
 Why?
Racism
1
2023
151
0.160
 Why?
India
1
2021
218
0.160
 Why?
Dacarbazine
3
2015
100
0.160
 Why?
Tibial Meniscus Injuries
1
2021
62
0.160
 Why?
Microcirculation
2
2017
138
0.160
 Why?
Perfusion Imaging
1
2020
65
0.160
 Why?
Radiometry
1
2020
56
0.160
 Why?
Hyperemia
1
2020
49
0.160
 Why?
Health Information Exchange
1
2020
24
0.160
 Why?
Medical Records Systems, Computerized
2
2013
95
0.160
 Why?
Carcinoma, Squamous Cell
2
2015
641
0.150
 Why?
Biomarkers, Tumor
3
2016
1313
0.150
 Why?
Brain Ischemia
1
2023
358
0.150
 Why?
Signal Processing, Computer-Assisted
2
2017
151
0.150
 Why?
Cerebellar Neoplasms
1
2022
177
0.150
 Why?
Brain Diseases
1
2021
152
0.150
 Why?
Area Under Curve
4
2021
330
0.150
 Why?
Low Back Pain
1
2021
106
0.150
 Why?
Lung Injury
1
2022
237
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2023
675
0.150
 Why?
Vascular Endothelial Growth Factor A
2
2023
557
0.150
 Why?
Medulloblastoma
1
2022
215
0.150
 Why?
Appendicitis
1
2021
148
0.150
 Why?
Positron Emission Tomography Computed Tomography
1
2020
117
0.150
 Why?
Antineoplastic Agents, Alkylating
2
2018
72
0.150
 Why?
Aneurysm, Ruptured
1
2019
38
0.150
 Why?
Capillary Permeability
1
2019
134
0.150
 Why?
Age Determination by Skeleton
1
2018
16
0.150
 Why?
Risk Assessment
5
2026
3671
0.140
 Why?
Treatment Outcome
8
2023
11679
0.140
 Why?
Blood-Brain Barrier
2
2017
155
0.140
 Why?
Cone-Beam Computed Tomography
1
2018
30
0.140
 Why?
Models, Biological
4
2024
1821
0.140
 Why?
Linear Models
1
2021
854
0.140
 Why?
Drug Resistance, Neoplasm
1
2024
881
0.140
 Why?
Colonic Neoplasms
1
2021
259
0.140
 Why?
Intracranial Aneurysm
1
2019
103
0.140
 Why?
Arteries
2
2019
259
0.140
 Why?
Ventricular Dysfunction, Right
1
2021
248
0.140
 Why?
Antibodies, Monoclonal, Humanized
1
2024
985
0.130
 Why?
Medical Record Linkage
1
2018
68
0.130
 Why?
Global Health
1
2021
401
0.130
 Why?
Prospective Studies
7
2023
7990
0.130
 Why?
Gadolinium
1
2017
84
0.130
 Why?
Polysaccharides, Bacterial
1
2017
67
0.130
 Why?
Diagnosis, Differential
3
2019
1489
0.130
 Why?
Bayes Theorem
2
2016
433
0.130
 Why?
Respiratory Insufficiency
1
2021
326
0.130
 Why?
Preoperative Period
1
2017
149
0.130
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1953
0.130
 Why?
Gray Matter
1
2018
91
0.130
 Why?
Patient Readmission
1
2022
758
0.120
 Why?
North America
3
2024
310
0.120
 Why?
Computer Simulation
5
2024
1025
0.120
 Why?
Skin Diseases, Genetic
1
2016
13
0.120
 Why?
Chronic Pain
1
2021
290
0.120
 Why?
Blood Vessels
1
2017
171
0.120
 Why?
Pharyngeal Muscles
1
2016
5
0.120
 Why?
Nasopharyngeal Neoplasms
1
2016
20
0.120
 Why?
SEER Program
3
2011
224
0.120
 Why?
Angiogenesis Inhibitors
2
2016
237
0.120
 Why?
National Cancer Institute (U.S.)
3
2020
52
0.120
 Why?
Blood Volume Determination
1
2015
5
0.110
 Why?
Vascular Malformations
1
2016
50
0.110
 Why?
Liver Cirrhosis
1
2017
288
0.110
 Why?
Acute Kidney Injury
1
2023
865
0.110
 Why?
Fibrosis
1
2017
548
0.110
 Why?
Positron-Emission Tomography
4
2021
323
0.110
 Why?
Cranial Irradiation
1
2015
85
0.110
 Why?
Physical Phenomena
1
2014
13
0.110
 Why?
Organs at Risk
1
2014
37
0.110
 Why?
Societies, Medical
3
2024
887
0.110
 Why?
Radiation Injuries
1
2016
151
0.110
 Why?
Birth Weight
3
2023
522
0.110
 Why?
Brachial Plexus
1
2014
35
0.110
 Why?
Longitudinal Studies
2
2019
2947
0.100
 Why?
Aged, 80 and over
5
2018
8265
0.100
 Why?
Chemoradiotherapy, Adjuvant
2
2011
44
0.100
 Why?
Tumor Microenvironment
1
2018
732
0.100
 Why?
Deglutition Disorders
1
2016
147
0.100
 Why?
Administration, Oral
1
2016
847
0.100
 Why?
Joint Instability
1
2016
182
0.100
 Why?
Mutation
3
2024
4089
0.100
 Why?
Computer-Assisted Instruction
1
2014
71
0.100
 Why?
Arteriovenous Malformations
1
2013
29
0.100
 Why?
Bias
3
2024
202
0.100
 Why?
Computer Literacy
1
2013
5
0.100
 Why?
Health Information Systems
1
2013
16
0.100
 Why?
Young Adult
7
2018
14105
0.090
 Why?
Survival Rate
3
2018
2089
0.090
 Why?
Terminology as Topic
1
2014
255
0.090
 Why?
Otorhinolaryngologic Neoplasms
1
2011
2
0.090
 Why?
Nomograms
1
2011
59
0.080
 Why?
Research Design
2
2014
1135
0.080
 Why?
Workload
1
2013
170
0.080
 Why?
Feasibility Studies
2
2014
1095
0.080
 Why?
Child
8
2024
22633
0.080
 Why?
Support Vector Machine
2
2021
36
0.080
 Why?
Muscle, Skeletal
1
2020
1795
0.080
 Why?
Papillomaviridae
2
2023
115
0.070
 Why?
Periodicals as Topic
1
2012
203
0.070
 Why?
Emergency Service, Hospital
1
2021
2310
0.070
 Why?
Liver
1
2017
1887
0.070
 Why?
Oregon
1
2008
76
0.070
 Why?
Total Quality Management
1
2008
57
0.070
 Why?
Lower Extremity
2
2023
438
0.070
 Why?
United States
5
2024
15966
0.070
 Why?
Exercise
1
2020
2201
0.070
 Why?
MEDLINE
1
2008
20
0.070
 Why?
Dilatation, Pathologic
2
2018
62
0.070
 Why?
Breast
2
2019
158
0.070
 Why?
Follow-Up Studies
3
2024
5408
0.070
 Why?
Protein Kinase Inhibitors
1
2013
969
0.060
 Why?
Randomized Controlled Trials as Topic
2
2025
1720
0.060
 Why?
Monte Carlo Method
2
2017
155
0.060
 Why?
Electronic Health Records
1
2015
1173
0.060
 Why?
Cluster Analysis
1
2007
521
0.060
 Why?
Clinical Protocols
2
2019
282
0.060
 Why?
Tanzania
1
2025
73
0.060
 Why?
Vaginal Smears
1
2025
55
0.060
 Why?
Proof of Concept Study
1
2024
85
0.050
 Why?
Netherlands
1
2024
82
0.050
 Why?
Critical Illness
2
2021
891
0.050
 Why?
Physicians
1
2013
939
0.050
 Why?
Kinetics
2
2019
1627
0.050
 Why?
Intensive Care Units, Neonatal
2
2018
279
0.050
 Why?
Brain Infarction
1
2023
23
0.050
 Why?
Ethers, Cyclic
1
2023
11
0.050
 Why?
DNA, Viral
1
2025
358
0.050
 Why?
Troponin T
1
2023
65
0.050
 Why?
Benzofurans
1
2023
26
0.050
 Why?
Models, Theoretical
2
2021
582
0.050
 Why?
X-Rays
1
2022
31
0.050
 Why?
DNA Helicases
1
2024
143
0.050
 Why?
Data Curation
1
2022
21
0.050
 Why?
Adrenal Glands
1
2022
77
0.050
 Why?
Smartphone
1
2023
102
0.050
 Why?
Quinazolines
2
2013
266
0.040
 Why?
Logistic Models
2
2021
2117
0.040
 Why?
Health Services
1
2022
115
0.040
 Why?
Limb Salvage
1
2022
70
0.040
 Why?
Cross-Sectional Studies
2
2024
5868
0.040
 Why?
Antineoplastic Agents, Immunological
1
2024
199
0.040
 Why?
Vagina
1
2024
201
0.040
 Why?
Edema
1
2022
124
0.040
 Why?
Utilization Review
1
2021
39
0.040
 Why?
Receptors, GABA
1
2021
13
0.040
 Why?
Nepal
1
2021
32
0.040
 Why?
Genetic Therapy
1
2023
313
0.040
 Why?
Case-Control Studies
2
2019
3604
0.040
 Why?
Massachusetts
1
2021
180
0.040
 Why?
Neoadjuvant Therapy
1
2024
462
0.040
 Why?
Early Diagnosis
1
2021
249
0.040
 Why?
Genotype
1
2025
1833
0.040
 Why?
Clinical Trials as Topic
2
2016
1053
0.040
 Why?
Abdomen
1
2021
141
0.040
 Why?
Incidence
2
2020
2879
0.040
 Why?
Seizures
1
2024
460
0.040
 Why?
Internationality
1
2021
156
0.040
 Why?
Cell Cycle Proteins
1
2024
628
0.040
 Why?
Ankle
1
2020
63
0.040
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2019
29
0.040
 Why?
Models, Statistical
2
2016
681
0.040
 Why?
Indoles
2
2013
501
0.040
 Why?
Hematopoietic Stem Cells
1
2023
420
0.040
 Why?
Disease Progression
2
2020
2847
0.040
 Why?
Hand Bones
1
2018
3
0.040
 Why?
Risk
1
2021
911
0.040
 Why?
Infant, Low Birth Weight
1
2020
153
0.040
 Why?
Quality Control
1
2019
163
0.040
 Why?
Nuclear Proteins
1
2024
748
0.040
 Why?
Bevacizumab
1
2019
167
0.040
 Why?
Arthroscopy
1
2021
267
0.040
 Why?
Reference Values
1
2020
797
0.040
 Why?
Genomics
1
2024
834
0.040
 Why?
Radiation Exposure
1
2019
63
0.040
 Why?
Hyperlipidemias
1
2019
122
0.040
 Why?
Ventricular Function, Right
1
2021
297
0.040
 Why?
Medical Oncology
1
2021
332
0.030
 Why?
Hemizygote
1
2017
5
0.030
 Why?
Carbon Tetrachloride
1
2017
13
0.030
 Why?
Half-Life
1
2017
151
0.030
 Why?
Diabetic Retinopathy
1
2020
208
0.030
 Why?
Diffusion
1
2017
121
0.030
 Why?
Permeability
1
2017
168
0.030
 Why?
Skull
1
2018
158
0.030
 Why?
Chemotherapy, Adjuvant
1
2018
421
0.030
 Why?
Ecosystem
1
2022
589
0.030
 Why?
Asymptomatic Diseases
1
2017
102
0.030
 Why?
Tissue Distribution
1
2017
327
0.030
 Why?
Outpatients
1
2021
442
0.030
 Why?
Signal-To-Noise Ratio
1
2016
73
0.030
 Why?
Information Dissemination
1
2019
223
0.030
 Why?
Expert Systems
1
2016
4
0.030
 Why?
Prostate
1
2017
158
0.030
 Why?
Palate, Soft
1
2016
11
0.030
 Why?
Heart Ventricles
1
2021
760
0.030
 Why?
Respiration, Artificial
1
2021
708
0.030
 Why?
Dose-Response Relationship, Radiation
1
2016
140
0.030
 Why?
Evaluation Studies as Topic
1
2016
166
0.030
 Why?
Transcription Factors
1
2024
1741
0.030
 Why?
Antineoplastic Protocols
1
2015
6
0.030
 Why?
Video Recording
1
2017
212
0.030
 Why?
Molecular Imaging
1
2016
55
0.030
 Why?
Magnetic Resonance Angiography
1
2017
251
0.030
 Why?
Platelet Count
1
2015
96
0.030
 Why?
Radiotherapy Dosage
1
2016
289
0.030
 Why?
Perfusion
1
2016
250
0.030
 Why?
Motion
1
2015
100
0.030
 Why?
Cerebrovascular Circulation
1
2017
280
0.030
 Why?
Diffusion Tensor Imaging
1
2015
73
0.030
 Why?
Disease-Free Survival
1
2016
769
0.030
 Why?
Thoracic Neoplasms
1
2014
39
0.030
 Why?
Intensive Care Units
1
2021
916
0.030
 Why?
Mass Spectrometry
1
2017
750
0.030
 Why?
Comorbidity
1
2019
1658
0.030
 Why?
Image Enhancement
1
2015
199
0.030
 Why?
Carcinoma
1
2016
228
0.030
 Why?
DNA Modification Methylases
1
2013
18
0.030
 Why?
DNA Repair Enzymes
1
2013
29
0.030
 Why?
Congresses as Topic
1
2015
221
0.020
 Why?
Argentina
1
2013
30
0.020
 Why?
Child, Preschool
2
2018
11787
0.020
 Why?
Molecular Targeted Therapy
1
2016
432
0.020
 Why?
Pandemics
1
2021
1694
0.020
 Why?
Statistics, Nonparametric
1
2013
427
0.020
 Why?
Fluorescein Angiography
1
2013
189
0.020
 Why?
Adolescent
3
2018
22428
0.020
 Why?
Smoking
1
2019
1472
0.020
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
230
0.020
 Why?
Life Tables
1
2011
21
0.020
 Why?
Effect Modifier, Epidemiologic
1
2011
8
0.020
 Why?
Hemodynamics
1
2016
1121
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2013
851
0.020
 Why?
Tumor Suppressor Proteins
1
2013
321
0.020
 Why?
Time Factors
1
2022
7173
0.020
 Why?
Educational Status
1
2013
467
0.020
 Why?
Polymerase Chain Reaction
1
2013
1054
0.020
 Why?
Pregnancy
1
2023
7190
0.020
 Why?
Hypertension
1
2019
1263
0.020
 Why?
Diabetes Mellitus
1
2019
1098
0.020
 Why?
Probability
1
2011
310
0.020
 Why?
Hospitalization
1
2021
2433
0.020
 Why?
Lymphatic Metastasis
1
2011
333
0.020
 Why?
Pilot Projects
1
2015
1886
0.020
 Why?
Rats
1
2017
5597
0.020
 Why?
Kaplan-Meier Estimate
1
2011
965
0.020
 Why?
PubMed
1
2008
15
0.020
 Why?
Ultrasonography
1
2012
770
0.020
 Why?
Disease Models, Animal
1
2017
4557
0.020
 Why?
Neoplasm Staging
1
2011
1462
0.020
 Why?
Attitude of Health Personnel
1
2013
1185
0.010
 Why?
Internship and Residency
1
2014
1257
0.010
 Why?
Age Factors
1
2011
3333
0.010
 Why?
Mice
1
2017
18339
0.010
 Why?
Animals
1
2017
38058
0.010
 Why?
Kalpathy-Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (405) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)